Dong-A Socio Holdings Co Ltd (000640):企業の財務・戦略的SWOT分析

◆英語タイトル:Dong-A Socio Holdings Co Ltd (000640) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C0581
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Dong-A Socio Holdings Co Ltd (000640) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Dong-A Socio Holdings Co Ltd (Dong-A Socio Holdings), formerly Dong-A Pharmaceutical Co., Ltd., offers business management services. It is a subsidiary of Dong-A Socio Group. It operates in various markets such as pharmaceuticals, food and beverages, logistics, IT, and materials. The group focuses on new business investments, development of biomedicines and research and development of new innovative drugs. Its main business areas include the manufacture of over-the-counter (OTC) and ethical drugs (ETC). Its major products include Bacchus-F, Bacchus-D, Panpyrin, Benachio, Myvlart Tab, Tempo and Eyebon. It also manufactures active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. Dong-A Socio Holdings is headquartered in Seoul, South Korea.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Dong-A Socio Holdings Co Ltd – Key Facts 5
Dong-A Socio Holdings Co Ltd – Key Employees 6
Dong-A Socio Holdings Co Ltd – Major Products and Services 7
Dong-A Socio Holdings Co Ltd – History 9
Dong-A Socio Holdings Co Ltd – Company Statement 12
Dong-A Socio Holdings Co Ltd – Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Joint Venture 13
Section 2 – Company Analysis 15
Company Overview 15
Dong-A Socio Holdings Co Ltd – Business Description 16
Dong-A Socio Holdings Co Ltd – SWOT Analysis 17
SWOT Analysis – Overview 17
Dong-A Socio Holdings Co Ltd – Strengths 17
Dong-A Socio Holdings Co Ltd – Weaknesses 18
Dong-A Socio Holdings Co Ltd – Opportunities 19
Dong-A Socio Holdings Co Ltd – Threats 20
Dong-A Socio Holdings Co Ltd – Key Competitors 21
Section 3 – Company Financial Ratios 22
Financial Ratios – Capital Market Ratios 22
Financial Ratios – Annual Ratios 23
Performance Chart 26
Financial Performance 26
Financial Ratios – Interim Ratios 27
Financial Ratios – Ratio Charts 28
Section 4 – Company’s Lifesciences Financial Deals and Alliances 29
Dong-A Socio Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Dong-A Socio Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
Dong-A Socio Holdings Co Ltd, Recent Deals Summary 31
Section 5 – Appendix 32
Methodology 32
Ratio Definitions 32
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Dong-A Socio Holdings Co Ltd, Key Facts 5
Dong-A Socio Holdings Co Ltd, Key Employees 6
Dong-A Socio Holdings Co Ltd, Major Products and Services 7
Dong-A Socio Holdings Co Ltd, History 9
Dong-A Socio Holdings Co Ltd, Subsidiaries 13
Dong-A Socio Holdings Co Ltd, Joint Venture 13
Dong-A Socio Holdings Co Ltd, Key Competitors 21
Dong-A Socio Holdings Co Ltd, Ratios based on current share price 22
Dong-A Socio Holdings Co Ltd, Annual Ratios 23
Dong-A Socio Holdings Co Ltd, Annual Ratios (Cont...1) 24
Dong-A Socio Holdings Co Ltd, Annual Ratios (Cont...2) 25
Dong-A Socio Holdings Co Ltd, Interim Ratios 27
Dong-A Socio Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Dong-A Socio Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
Dong-A Socio Holdings Co Ltd, Recent Deals Summary 31
Currency Codes 32
Capital Market Ratios 32
Equity Ratios 33
Profitability Ratios 33
Cost Ratios 34
Liquidity Ratios 34
Leverage Ratios 35
Efficiency Ratios 35

List of Figures
Dong-A Socio Holdings Co Ltd, Performance Chart (2013 - 2017) 26
Dong-A Socio Holdings Co Ltd, Ratio Charts 28
Dong-A Socio Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Dong-A Socio Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 30

★海外企業調査レポート[Dong-A Socio Holdings Co Ltd (000640):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Clarion Co Ltd:企業の戦略的SWOT分析
    Clarion Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Bioanalytical Systems Inc (BASI):企業の財務・戦略的SWOT分析
    Summary Bioanalytical Systems Inc (Bioanalytical Systems) is a contract research organization. It provides drug discovery and development services, and analytical instruments. The company’s contract research services include screening and pharmacological testing, formulation development, preclinical …
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development-製薬・医療分野:企業M&A・提携分析
    Summary Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), a subsidiary of National Institutes of Health is a research institute that conducts and supports laboratory research, clinical trials, and epidemiological studies. The institute conducts research in the …
  • Colt Technology Services Group Ltd:企業の戦略的SWOT分析
    Colt Technology Services Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • InVivo Therapeutics Corp:企業の製品パイプライン分析2018
    Summary InVivo Therapeutics Corp (InVivo), a subsidiary of InVivo Therapeutics Holdings Corp, is a medical device company that offers therapeutic products. The company develops and commercializes groundbreaking treatments for spinal cord injuries. Its products include biocompatible neuro spinal scaf …
  • eNeura Inc:医療機器:M&Aディール及び事業提携情報
    Summary eNeura Inc (eNeura) formerly eNeura Therapeutics LLC is a medical device manufacturing company that offers portable, non-invasive transcranial magnetic stimulation devices for treating migraine. The company offers products such as flagship product and eNeura Spring TMS device, among others. …
  • AgaMatrix Inc-医療機器分野:企業M&A・提携分析
    Summary AgaMatrix Inc (AgaMatrix) is a medical device company that offers biosensors. The company designs, develops and manufactures diabetes products for pharmaceutical companies. Its products include advanced blood glucose monitoring systems, and diabetes data management systems. AgaMatrix uses pr …
  • Teledyne Technologies Incorporated:企業の戦略・SWOT・財務情報
    Teledyne Technologies Incorporated - Strategy, SWOT and Corporate Finance Report Summary Teledyne Technologies Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • China Everbright Bank Co., Ltd.:戦略・SWOT・企業財務分析
    China Everbright Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary China Everbright Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Alcazar Energy Ltd-エネルギー分野:企業M&A・提携分析
    Summary Alcazar Energy Ltd (Alcazar Energy) is a renewable energy company which develops and produces power generation projects with focus on solar photovoltaic (PV) and onshore wind technologies. The company specializes in origination, development, structuring, acquisition and operation of renewabl …
  • Delaware North Companies Inc:企業の戦略的SWOT分析
    Delaware North Companies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Straumann Holding AG (STMN):医療機器:M&Aディール及び事業提携情報
    Summary Straumann Holding AG (Straumann) is a provider of tooth replacement and orthodontic solutions. The company researches, develops, manufactures and markets dental implants, instruments, digital equipment, CADCAM prosthetics, dental biomaterials, software and clear aligners for application in t …
  • Ascentage Pharma Group Corp Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Ascentage Pharma Group Corp Ltd (Ascentage Pharma) is a biopharmaceutical company that discovers and develops targeted small-molecule therapeutics for the treatment of cancers, hepatitis B and age-related diseases. The company’s pipeline product includes apoptosis compounds and kinase inhibi …
  • EnCana Corp (ECA):石油・ガス:M&Aディール及び事業提携情報
    Summary EnCana Corp (EnCana) is an oil and gas producer. The company explores, develops, produces and markets natural gas, oil and natural gas liquids (NGLs). Its major resource plays include Montney, Duvernay, Wheatland Oil play, Deep Panuke, Horn River and other emerging plays in Canada. In the US …
  • Grenergy Renovables SL (GRE):電力:M&Aディール及び事業提携情報
    Summary Grenergy Renovables SL (Grenergy Renovables), a subsidiary of DARUAN Venture Capital SCR, is an alternative energy company that generates renewable energy through solar photovoltaic plants. The company provides services such as construction, engineering, and procurement services, project dev …
  • Saudi Electricity Co:企業の発電所・SWOT分析2018
    Saudi Electricity Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • Raya Holding (RAYA):企業の財務・戦略的SWOT分析
    Raya Holding (RAYA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Lucigen Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Lucigen Corp (Lucigen), a subsidiary of LGC Ltd, is a medical device company that discovers, manufactures, and commercializes molecular biology product. The company’s products comprise competent cells, nextgen seq, enzymes, cloning systems, PCR and amplification, cloning test kits and vector …
  • FLIR Systems Inc:企業の戦略・SWOT・財務情報
    FLIR Systems Inc - Strategy, SWOT and Corporate Finance Report Summary FLIR Systems Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Adamis Pharmaceuticals Corp (ADMP):製薬・医療:M&Aディール及び事業提携情報
    Summary Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc, is a biopharmaceutical company that develops therapies in areas of respiratory disease and allergy. The company offers pipeline product, epinephrine pre-filled syringe is developed for anaphylactic reactions such as …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆